Includes all AIM, ASX, CBOE, CSE, LSE, TSX and TSXV companies with US symbols
Loading...
Get Featured
Pink

TXTMProText Mobility, Inc.

Loading price...
Loading price changes...
Loading market cap...

Price Chart

Loading chart...

About ProText Mobility, Inc. (TXTM)

ProText Mobility, Inc. (TXTM) is a Biotechnology company headquartered in Fort Lauderdale, FL, United States whose shares trade over-the-counter on the Pink tier.

Protext is a Biotech Company developing a Hemp/CBD -- Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Through its wholly owned subsidiary RSAMMD Acquisitions LLC ("RSAMMDA") and under the leadership of its founders Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen we partner with leading hospitals and universities globally to advance the clinical benefits and applications of cannabis. Mr. Du Plooy is a South African pioneer in the research and cultivation. Dr. J operates a 5000-hectare farm in New Castle, South Africa and holds hemp permit issued by the Government of South Africa, Department of Agriculture. Together the RSAMMDA founders have been at the forefront of medical cannabis legislation and South African cannabis legalization, which took place in September 2018. The company is committed to the advancement of technology and scientific research that leads to an improved quality of life for patients around the world.

Products and services

Company operates two wholly owned subsidiaries: Plandai Biotechnology South Africa (Pty) Ltd. and Cannabis Biosciences, Inc. The Company is engaged in the research, testing and commercialization of highly bioavailable botanical products-all-natural ingredients to be formulated for nutraceutical and/or pharmaceutical applications

TXTM key facts

Ticker symbol
TXTM
Market tier
Pink
Headquarters
Fort Lauderdale, FL, United States
Country of incorporation
US
Year of incorporation
2001
Employees
10
Estimated market cap
$7.91M (as of Apr 10, 2025)
Shares outstanding
8,791,221,631
Reporting standard
Alternative Reporting Standard
Audit status
Unaudited
Fiscal year end
12/31
Latest filing
Quarterly Report (Sep 30, 2024)

ProText Mobility, Inc. leadership

  • Dr. Ahmed Jamaloodeen — President
  • Dylon Du Plooy — CEO

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with T

Press Releases

Loading press releases...

Latest News

Loading news...

SPONSORED
Loading ads...
SPONSORED
Loading ads...

Key Statistics

Major Holders

Loading...

Loading modules...

AI-Powered Stock Analysis

Get a concise 600-word investment analysis for ProText Mobility, Inc. (TXTM) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.

Still in beta - Please send feedback after generating your analysis to help us improve!

Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!

By submitting, you agree to our Privacy Policy and Terms of Service. We'll add you to our newsletter but you can unsubscribe at any time.

Investor Reviews

Investor Reviews (0)

Loading reviews...

Get Verified

Is this your company?

Get verified and take control of your company page. Add your verified badge, edit information, and showcase your business to investors.

Low Cost
Quick Setup
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...
SPONSORED
Loading ads...

Company Profile

Loading company profile data...

Contact Information

Investor Relations Email
Not provided
Headquarters Address
One West Las Olas Blvd
Fort Lauderdale, FL, 33301
United States

Company Leadership

Chief Executive Officer

C
CEO Information Not Available
Chief Executive Officer

Company Officers

Dr. Ahmed Jamaloodeen
President
Dylon Du Plooy
CEO

Social Media

Business Details

Stock Details

Loading modules...